MedTrace Logo

Effects of Tadalafil on LMR and MHR in Patients With ED

NCT03918993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2019-04-23

No results posted yet for this study

Summary

The aim of the study was to investigate whether daily 5 mg tadalafil over eight weeks affects to Lymphocyte/Monocyte ratio (LMR) and Monocyte/High-Density Lipoprotein ratio (MHR) in patients with erectile dysfunction (ED).

Thirty-one patients with organic ED and 31 healthy controls between July 2017 and November 2018 were included in this retrospective study. To avoid bias, the patients were randomly selected and the controls were also incorporated consecutively. The presence of ED was determined according to the International Erectile Function Index-5 (IIEF-5). The patients and the controls were evaluated in terms of IIEF-5, complete blood count, serum biochemistry, LMR, and MHR.

Conditions

Interventions

DRUG

Tadalafil 5mg tablet

Once-a-day 5 mg dose of tadalafil for 8 weeks

Sponsors & Collaborators

  • Ondokuz Mayıs University

    collaborator OTHER

  • Samsun Liv Hospital

    lead OTHER

Principal Investigators

  • Yakup Bostancı, MD · Ondokuz Mayıs University

Eligibility

Min Age
39 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-14
Primary Completion
2019-03-10
Completion
2019-04-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03918993 on ClinicalTrials.gov